Post Market Clinical Experience Study of Sientra 207 Breast Implants

NCT02905617 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 113

Last updated 2023-07-03

No results posted yet for this study

Summary

A 12-month study to evaluate the clinical experience with Sientra 207 Silicone Gel Breast Implants

Conditions

  • Breast Augmentation
  • Breast Revision-Augmentation

Interventions

DEVICE

Sientra 207 Silicone Gel Breast Implant

The Sientra 207 Silicone Gel Breast Implant is a textured, round device with high-strength cohesive plus (HSC+) silicone gel fill.

Sponsors & Collaborators

  • Tiger Biosciences, LLC.

    lead INDUSTRY

Principal Investigators

  • Sientra, Inc. · Sponsor GmbH

Eligibility

Min Age
22 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2020-07-15
Completion
2020-07-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02905617 on ClinicalTrials.gov